Q&A: The IND Journey Phase I – Navigating Success
Advarra
JULY 19, 2022
A: This is a complex topic and is best outlined in the FDA’s guidance document. Q: What is the typical time period between the submission of the briefing package and the pre-IND meeting? A: The FDA’s guidance document indicates the briefing package is submitted four weeks before the meeting. Could you please confirm?
52 
Let's personalize your content